Protein Sequencing Market

Protein Sequencing Market


The protein sequencing market is anticipated to expand from $1.2 billion in 2023 to $3.8 billion by 2033, reflecting a CAGR of approximately 11.5%.

The Protein Sequencing Market encompasses the industry dedicated to identifying the amino acid sequence of proteins, essential for understanding biological processes and drug development. It includes technologies such as mass spectrometry and Edman degradation, alongside services and software for data analysis. This market supports advancements in personalized medicine, biotechnology, and proteomics research, driving innovation in diagnostics and therapeutics.

The Protein Sequencing Market is witnessing robust expansion, largely fueled by advancements in genomic research and proteomics. The mass spectrometry segment leads the market, owing to its high precision and efficiency in sequencing proteins. Edman degradation follows as the second-highest performing sub-segment, benefiting from its utility in determining amino acid sequences. Regionally, North America stands out as the dominant market, driven by substantial investments in research and development and a strong presence of key industry players. Europe emerges as the second-leading region, bolstered by supportive government initiatives and a growing emphasis on personalized medicine. Within countries, the United States leads, attributed to its cutting-edge technological infrastructure and extensive research activities. Germany ranks as the second most significant contributor, supported by its robust biotechnology sector and collaborative research frameworks. These dynamics underscore the market's potential for growth and innovation, presenting lucrative opportunities for stakeholders.

In 2023, the market is characterized by a robust volume, with an estimated 320 million assays conducted. The market segmentation reveals that mass spectrometry dominates with a 45% share, while Edman degradation holds 30%. Next-generation sequencing (NGS) captures 25%, reflecting a growing preference for precision and speed. The surge in demand for personalized medicine and proteomics research significantly boosts these segments. Key players, including Thermo Fisher Scientific, Agilent Technologies, and Shimadzu Corporation, are pivotal in shaping market dynamics through innovation and strategic partnerships.

Competitive and regulatory influences significantly impact the Protein Sequencing Market. The FDA's emphasis on precision medicine underscores the importance of regulatory compliance, affecting market strategies. Projections indicate a CAGR of 9% through 2033, driven by advancements in sequencing technologies and increased R&D investments. The competitive landscape is marked by strategic alliances and technological innovations, with companies focusing on enhancing sequencing accuracy and reducing costs. As the market evolves, opportunities abound in emerging economies, driven by healthcare infrastructure development and increased proteomics research funding.

Key Players

Pacific Biosciences, Oxford Nanopore Technologies, Illumina, BGI Genomics, Agilent Technologies, Bruker Corporation, Thermo Fisher Scientific, QIAGEN, Bio- Rad Laboratories, Roche Diagnostics, Shimadzu Corporation, Perkin Elmer, Waters Corporation, GE Healthcare, Danaher Corporation, Geno Technology, Sygnis AG, Nano String Technologies, Sciex, Promega Corporation

Sources

National Institutes of Health (NIH), European Molecular Biology Laboratory (EMBL), Genome Canada, Human Proteome Organization (HUPO), U.S. Food and Drug Administration (FDA), European Proteomics Association (EuPA), American Society for Mass Spectrometry (ASMS), International Society for Computational Biology (ISCB), Wellcome Trust, National Center for Biotechnology Information (NCBI), Biotechnology and Biological Sciences Research Council (BBSRC), Japan Society for Proteome Sciences (JSPS), American Society for Biochemistry and Molecular Biology (ASBMB), European Bioinformatics Institute (EBI), Cold Spring Harbor Laboratory, International Conference on Proteomics and Bioinformatics, Annual World Congress on Biomarkers and Clinical Research, Gordon Research Conferences on Proteomics, Keystone Symposia on Molecular and Cellular Biology, Federation of American Societies for Experimental Biology (FASEB)

Value Chain Analysis

The value chain analysis for the Aerospace Carbon Fiber Market encompasses five distinct stages, each playing a pivotal role in ensuring the seamless delivery of high-quality carbon fiber products to the aerospace industry.

Raw Material Procurement: This stage involves identifying and securing sources of raw materials, primarily polyacrylonitrile (PAN) and pitch, which are essential for carbon fiber production. It is imperative to assess the availability, quality, and sustainability of these materials. Engaging with reliable suppliers, understanding market dynamics, pricing trends, and potential risks associated with sourcing, such as geopolitical factors or environmental regulations, are crucial to maintaining a stable supply chain.

Research and Development (R&D): In this phase, the focus is on conducting comprehensive market analysis and trend forecasting to anticipate future demands. Feasibility studies and rigorous experiments are undertaken to develop innovative carbon fiber products or enhance existing ones. R&D efforts are directed towards improving the mechanical properties, such as tensile strength and stiffness, while also exploring cost-effective production methods. Collaboration with academic institutions and industry partners can further accelerate innovation.

Product Approval: This stage involves navigating the complex landscape of legal requirements, industry regulations, and certification processes specific to aerospace applications. Products undergo stringent testing for safety, efficacy, and environmental impact to ensure compliance with international standards. Obtaining approvals from regulatory bodies, such as the Federal Aviation Administration (FAA) or the European Union Aviation Safety Agency (EASA), is critical for market entry.

Large Scale Manufacturing: Optimizing production processes is paramount in this phase to achieve economies of scale. This involves process engineering, the integration of automation technologies, and robust supply chain management to enhance productivity and maintain quality. Continuous improvement initiatives focus on reducing costs, minimizing waste, and ensuring consistency in product specifications. Strategic investments in advanced manufacturing technologies, such as 3D weaving or automated fiber placement, can provide a competitive advantage.

Sales and Marketing: Understanding customer needs and preferences is essential for successful market penetration. This stage involves a thorough analysis of market trends and the competitive landscape to identify lucrative opportunities. Market segmentation, consumer behavior analysis, and the development of compelling branding strategies are employed to effectively position products in the market. Building strong relationships with key stakeholders, including aerospace manufacturers and suppliers, through targeted marketing campaigns and participation in industry events, is vital for driving sales and fostering long-term partnerships.

Research Scope
  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.
Our Research Scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

Please Note: This report will be delivered by publisher within 2-3 business days of order confirmation.


Chapter: 1
1.1 Market Definition
1.2 Market Segmentation
1.3 Regional Coverage
1.4 Key Company Profiles
1.5 Key Manufacturers Profiles
1.6 Data Snapshot
Executive Summary
Chapter: 2
2.1 Summary
2.2 Key Opinion Leaders
2.3 Key Highlights of the Market, by Technology
2.4 Key Highlights of the Market, by Application
2.5 Key Highlights of the Market, by End-user
2.6 Key Highlights of the Market, by Components
2.7 Key Highlights of the Market, by Protein type
2.8 Key Highlights of the Market, by Platform
2.9 Key Highlights of the Market, by North America
2.10 Key Highlights of the Market, by Europe
2.11 Key Highlights of the Market, by Asia-Pacific
2.12 Key Highlights of the Market, by Latin America
2.13 Key Highlights of the Market, by Middle East
2.14 Key Highlights of the Market, by Africa
Premium Insights on the Market
Chapter: 3
3.1 Market Attractiveness Analysis, by Region
3.2 Market Attractiveness Analysis, by Technology
3.3 Market Attractiveness Analysis, by Application
3.4 Market Attractiveness Analysis, by End-user
3.5 Market Attractiveness Analysis, by Components
3.6 Market Attractiveness Analysis, by Protein type
3.7 Market Attractiveness Analysis, by Platform
3.8 Market Attractiveness Analysis, by North America
3.9 Market Attractiveness Analysis, by Europe
3.10 Market Attractiveness Analysis, by Asia-Pacific
3.11 Market Attractiveness Analysis, by Latin America
3.12 Market Attractiveness Analysis, by Middle East
3.13 Market Attractiveness Analysis, by Africa
Market Analysis
Chapter: 4
4.1 Market Drivers
4.2 Market Trends
4.3 Market Restraints
4.4 Market Opportunities
4.5 Porters Five Forces Analysis
4.6 PESTLE Analysis
4.7 Value Chain Analysis
4.8 4Ps Model
4.9 ANSOFF Matrix
Market Strategy
Chapter: 5
5.1 Parent Market Analysis
5.2 Supply-Demand Analysis
5.3 Consumer Buying Interest
5.4 Case Study Analysis
5.5 Pricing Analysis
5.6 Regulatory Landscape
5.7 Supply Chain Analysis
5.8 Competition Product Analysis
5.9 Recent Developments
Market Size
Chapter: 6
6.1 Protein Sequencing Market Market Size, by Value
6.2 Protein Sequencing Market Market Size, by Volume
Protein Sequencing Market Market, by Type
Chapter: 7
7.1 Key Market Overview, Trends & Opportunity Analysis
7.2 Market Size and Forecast, by Technology
7.2.1 Market Size and Forecast, by Mass Spectrometry
7.2.1 Market Size and Forecast, by Edman Degradation
7.2.1 Market Size and Forecast, by N-terminal Sequencing
7.2.1 Market Size and Forecast, by Amino Acid Analysis
7.2.1 Market Size and Forecast, by Next-Generation Sequencing for Proteomics
7.3 Market Size and Forecast, by Application
7.3.1 Market Size and Forecast, by Biotherapeutics Characterization
7.3.1 Market Size and Forecast, by Proteomics Research
7.3.1 Market Size and Forecast, by Genetic Engineering
7.3.1 Market Size and Forecast, by Drug Discovery and Development
7.3.1 Market Size and Forecast, by Disease Diagnosis
7.3.1 Market Size and Forecast, by Other Life Sciences Applications
7.4 Market Size and Forecast, by End-user
7.4.1 Market Size and Forecast, by Academic and Research Institutes
7.4.1 Market Size and Forecast, by Pharmaceutical and Biotechnology
7.4.1 Market Size and Forecast, by Contract Research Organizations
7.4.1 Market Size and Forecast, by Clinical Laboratories
7.5 Market Size and Forecast, by Components
7.5.1 Market Size and Forecast, by Reagents and Consumables
7.5.1 Market Size and Forecast, by Instruments
7.5.1 Market Size and Forecast, by Software for Data Analysis
7.5.1 Market Size and Forecast, by Sequencing Services
7.6 Market Size and Forecast, by Protein type
7.6.1 Market Size and Forecast, by Monoclonal Antibodies
7.6.1 Market Size and Forecast, by Enzymes
7.6.1 Market Size and Forecast, by Hormones
7.6.1 Market Size and Forecast, by Structural Proteins
7.6.1 Market Size and Forecast, by Others
7.7 Market Size and Forecast, by Platform
7.7.1 Market Size and Forecast, by Liquid Chromatography
7.7.1 Market Size and Forecast, by Capillary Electrophoresis
7.7.1 Market Size and Forecast, by Protein Microarrays
7.7.1 Market Size and Forecast, by Protein Fractionation
Protein Sequencing Market Market, by Region
Chapter: 8
8.1 Overview
8.2 North America
8.3.1 Key Market Trends and Opportunities
8.3.2 North America Market Size and Forecast, by Technology
8.3.3 North America Market Size and Forecast, by Mass Spectrometry
8.3.4 North America Market Size and Forecast, by Edman Degradation
8.3.5 North America Market Size and Forecast, by N-terminal Sequencing
8.3.6 North America Market Size and Forecast, by Amino Acid Analysis
8.3.7 North America Market Size and Forecast, by Next-Generation Sequencing for Proteomics
8.3.8 North America Market Size and Forecast, by Application
8.3.9 North America Market Size and Forecast, by Biotherapeutics Characterization
8.3.10 North America Market Size and Forecast, by Proteomics Research
8.3.11 North America Market Size and Forecast, by Genetic Engineering
8.3.12 North America Market Size and Forecast, by Drug Discovery and Development
8.3.13 North America Market Size and Forecast, by Disease Diagnosis
8.3.14 North America Market Size and Forecast, by Other Life Sciences Applications
8.3.15 North America Market Size and Forecast, by End-user
8.3.16 North America Market Size and Forecast, by Academic and Research Institutes
8.3.17 North America Market Size and Forecast, by Pharmaceutical and Biotechnology
8.3.18 North America Market Size and Forecast, by Contract Research Organizations
8.3.19 North America Market Size and Forecast, by Clinical Laboratories
8.3.20 North America Market Size and Forecast, by Components
8.3.21 North America Market Size and Forecast, by Reagents and Consumables
8.3.22 North America Market Size and Forecast, by Instruments
8.3.23 North America Market Size and Forecast, by Software for Data Analysis
8.3.24 North America Market Size and Forecast, by Sequencing Services
8.3.25 North America Market Size and Forecast, by Protein type
8.3.26 North America Market Size and Forecast, by Monoclonal Antibodies
8.3.27 North America Market Size and Forecast, by Enzymes
8.3.28 North America Market Size and Forecast, by Hormones
8.3.29 North America Market Size and Forecast, by Structural Proteins
8.3.30 North America Market Size and Forecast, by Others
8.3.31 North America Market Size and Forecast, by Platform
8.3.32 North America Market Size and Forecast, by Liquid Chromatography
8.3.33 North America Market Size and Forecast, by Capillary Electrophoresis
8.3.34 North America Market Size and Forecast, by Protein Microarrays
8.3.35 North America Market Size and Forecast, by Protein Fractionation
8.3.36 United States
8.3.37 United States Market Size and Forecast, by Technology
8.3.38 United States Market Size and Forecast, by Mass Spectrometry
8.3.39 United States Market Size and Forecast, by Edman Degradation
8.3.40 United States Market Size and Forecast, by N-terminal Sequencing
8.3.41 United States Market Size and Forecast, by Amino Acid Analysis
8.3.42 United States Market Size and Forecast, by Next-Generation Sequencing for Proteomics
8.3.43 United States Market Size and Forecast, by Application
8.3.44 United States Market Size and Forecast, by Biotherapeutics Characterization
8.3.45 United States Market Size and Forecast, by Proteomics Research
8.3.46 United States Market Size and Forecast, by Genetic Engineering
8.3.47 United States Market Size and Forecast, by Drug Discovery and Development
8.3.48 United States Market Size and Forecast, by Disease Diagnosis
8.3.49 United States Market Size and Forecast, by Other Life Sciences Applications
8.3.50 United States Market Size and Forecast, by End-user
8.3.51 United States Market Size and Forecast, by Academic and Research Institutes
8.3.52 United States Market Size and Forecast, by Pharmaceutical and Biotechnology
8.3.53 United States Market Size and Forecast, by Contract Research Organizations
8.3.54 United States Market Size and Forecast, by Clinical Laboratories
8.3.55 United States Market Size and Forecast, by Components
8.3.56 United States Market Size and Forecast, by Reagents and Consumables
8.3.57 United States Market Size and Forecast, by Instruments
8.3.58 United States Market Size and Forecast, by Software for Data Analysis
8.3.59 United States Market Size and Forecast, by Sequencing Services
8.3.60 United States Market Size and Forecast, by Protein type
8.3.61 United States Market Size and Forecast, by Monoclonal Antibodies
8.3.62 United States Market Size and Forecast, by Enzymes
8.3.63 United States Market Size and Forecast, by Hormones
8.3.64 United States Market Size and Forecast, by Structural Proteins
8.3.65 United States Market Size and Forecast, by Others
8.3.66 United States Market Size and Forecast, by Platform
8.3.67 United States Market Size and Forecast, by Liquid Chromatography
8.3.68 United States Market Size and Forecast, by Capillary Electrophoresis
8.3.69 United States Market Size and Forecast, by Protein Microarrays
8.3.70 United States Market Size and Forecast, by Protein Fractionation
8.3.71 Local Competition Analysis
8.3.72 Local Market Analysis
Competitive Landscape
Chapter: 9
9.1 Overview
9.2 Market Share Analysis
9.3 Key Player Positioning
9.4 Competitive Leadership Mapping
9.5 Star Players
9.6 Innovators
9.7 Emerging Players
9.8 Vendor Benchmarking
9.9 Developmental Strategy Benchmarking
9.10 New Product Developments
9.11 Product Launches
9.12 Business Expansions
9.13 Partnerships, Joint Ventures, and Collaborations
9.14 Mergers and Acquisitions
Company Profiles - Overview, Segments, Performance, Products, Key Strategies, SWOT Analysis
Chapter: 10
10.1 Thermo Fisher Scientific
10.2 Agilent Technologies
10.3 Bioinformatics Solutions
10.4 Rapid Novor
10.5 Shimadzu
10.6 JEOL
10.7 Bruker
10.8 ProteinSimple
10.9 Bio-Rad Laboratories
10.10 Illumina GenScript
10.11 IDT
10.12 Sciex
10.13 Promega
10.14 Takara Bio
10.15 New England Biolabs
10.16 Merck KGaA
10.17 Waters Corporation
10.18 PerkinElmer
10.19 GE Healthcare

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings